Expanded Access to Veliparib

Conditions

• Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
• Triple Negative Breast Cancer (TNBC)
• High Grade Serous Ovarian Cancer
• Patients Requiring Veliparib Suspension Formulation

Interventions

• DRUG: Veliparib

Sponsor

AbbVie